Understand the source comparison
Best Peptides for Executive Function: Mechanism and Application Comparison
Semax BDNF and NGF upregulation in prefrontal cortex; neuroprotection via PI3K/Akt pathway activation 600–3000mcg/day intranasal, divided doses Intranasal spray or drops 3–7 days for subjective effects; gene expression changes within 24 hours 1.5–2.3× increase
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Semax
- BDNF and NGF upregulation in prefrontal cortex; neuroprotection via PI3K/Akt pathway activation
- 600–3000mcg/day intranasal, divided doses
- Intranasal spray or drops
- 3–7 days for subjective effects; gene expression changes within 24 hours
- 1.5–2.3× increase in BDNF mRNA (J Mol Neurosci 2015)
- Working memory support under chronic stress; post-stroke cognitive recovery
- Selank
- Enkephalin metabolism modulation; indirect dopamine D2 receptor stabilization; anxiolytic via CRH suppression
- 300–600mcg/day intranasal, 1–2× daily
- 3–5 days for anxiety reduction; cognitive effects follow within 7 days
- 35–40% reduction in anxiety scores without sedation (Neurosci Behav Physiol 2009)
- Anxiety-driven executive function impairment; stress-induced cognitive dysregulation
- Dihexa
- HGF mimetic; c-Met receptor activation; promotes dendritic spine formation and synaptic density
- 5–20mg/day oral, single dose
- Oral (capsule or solution)
- 10–14 days for structural effects; sustained beyond treatment cessation
- 40% increase in hippocampal synaptophysin after 14 days (preclinical)
- Age-related cognitive decline; long-term cognitive enhancement via synaptogenesis
- N-Acetyl Semax Amidate
- Extended Semax variant with acetyl and amide modifications; longer half-life; enhanced BBB penetration
- 300–1200mcg/day intranasal
- Similar to standard Semax but with more gradual onset
- No direct human trials; extrapolated from Semax data with structural modification
- Researchers seeking sustained BDNF elevation with less frequent dosing
- P21 (Cerebrolysin-derived)
- CNTF (ciliary neurotrophic factor) mimetic; promotes neurogenesis and synaptic repair
- 5–10mg subcutaneous, 2–3× weekly
- Subcutaneous injection
- 7–14 days; effects cumulative over weeks
- Derived from Cerebrolysin, which showed cognitive improvement in vascular dementia trials
- Traumatic brain injury recovery; neurodegenerative disease research